Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
KeyCorp price target raised to $24 from $20 at Citi » 06:34
04/29/21
04/29
06:34
04/29/21
06:34
KEY

KeyCorp

$21.56 /

+0.12 (+0.56%)

Citi analyst Keith…

Citi analyst Keith Horowitz raised the firm's price target on KeyCorp to $24 from $20 and keeps a Neutral rating on the shares following the Q1 results.

ShowHide Related Items >><<
KEY KeyCorp
$21.56 /

+0.12 (+0.56%)

KEY KeyCorp
$21.56 /

+0.12 (+0.56%)

04/26/21 Wedbush
KeyCorp upgraded to Outperform at Wedbush on stronger revenue outlook
04/26/21 Wedbush
KeyCorp upgraded to Outperform from Neutral at Wedbush
04/21/21 RBC Capital
KeyCorp price target raised to $23 from $20 at RBC Capital
04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
KEY KeyCorp
$21.56 /

+0.12 (+0.56%)

KEY KeyCorp
$21.56 /

+0.12 (+0.56%)

KEY KeyCorp
$21.56 /

+0.12 (+0.56%)

Upgrade
KeyCorp upgraded to Outperform at Wedbush on stronger revenue outlook » 07:26
04/26/21
04/26
07:26
04/26/21
07:26
KEY

KeyCorp

$20.77 /

+0.755 (+3.77%)

As previously reported,…

As previously reported, Wedbush analyst Peter Winter upgraded KeyCorp to Outperform from Neutral with a price target of $25, up from $23. The analyst notes that coming out of Q1 earnings, Keycorp reported one of the best outlooks among his bank group. What stood out was a more positive revenue outlook, in terms of net interest income and fee income growth, plus, a slight increase in expense growth, Winter adds.

ShowHide Related Items >><<
KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

04/26/21 Wedbush
KeyCorp upgraded to Outperform from Neutral at Wedbush
04/21/21 RBC Capital
KeyCorp price target raised to $23 from $20 at RBC Capital
04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

Upgrade
KeyCorp upgraded to Outperform from Neutral at Wedbush » 06:32
04/26/21
04/26
06:32
04/26/21
06:32
KEY

KeyCorp

$20.77 /

+0.755 (+3.77%)

Wedbush analyst Peter…

Wedbush analyst Peter Winter upgraded KeyCorp to Outperform from Neutral.

ShowHide Related Items >><<
KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

04/21/21 RBC Capital
KeyCorp price target raised to $23 from $20 at RBC Capital
04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

KEY KeyCorp
$20.77 /

+0.755 (+3.77%)

Recommendations
KeyCorp price target raised to $23 from $20 at RBC Capital » 08:23
04/21/21
04/21
08:23
04/21/21
08:23
KEY

KeyCorp

$19.84 /

-0.59 (-2.89%)

RBC Capital analyst…

RBC Capital analyst Gerard Cassidy raised the firm's price target on KeyCorp to $23 from $20 and keeps an Outperform rating on the shares after its Q1 earnings beat. The company has been "rebuilt, de-risked, and better-managed", proving to investors that it is not the "KeyCorp of old" when it collapsed during the 2008 GFC from the weight of its non-performing assets, the analyst tells investors in a research note.

ShowHide Related Items >><<
KEY KeyCorp
$19.84 /

-0.59 (-2.89%)

KEY KeyCorp
$19.84 /

-0.59 (-2.89%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$19.84 /

-0.59 (-2.89%)

KEY KeyCorp
$19.84 /

-0.59 (-2.89%)

KEY KeyCorp
$19.84 /

-0.59 (-2.89%)

Hot Stocks
KeyCorp sees FY21 NII up low single digits vs. prior 'relatively stable' outlook » 07:38
04/20/21
04/20
07:38
04/20/21
07:38
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Sees FY21 noninterest…

Sees FY21 noninterest income up mid-single digits vs. prior low single digits outlook, with noninterest expense relatively stable vs. prior down low single digits outlook. Now sees FY21 net charge-offs to average loans 35-45bps vs. prior 50-60bps view. The GAAP tax rate is still expected to be about 19%. Sees loans relatively stable, with deposits up mid-single digits for FY21.

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Hot Stocks
KeyCorp sees long-term ROTCE 16%-19%, cash efficiency ratio 54%-56% » 07:37
04/20/21
04/20
07:37
04/20/21
07:37
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Sees positive operating…

Sees positive operating leverage for the long-term. Comments taken from Q1 earnings conference call presentation slides.

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Earnings
KeyCorp reports Q1 EPS 61c, consensus 48c » 06:42
04/20/21
04/20
06:42
04/20/21
06:42
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Reports Q1 revenue…

Reports Q1 revenue $1.75B, consensus $1.69B. Reports Q1 book value per share $16.22. Reports Q1 CET1 capital ratio 9.8%. "This was a strong start to the year for Key as we executed our strategy, grew and expanded client relationships, and delivered positive operating leverage. Our results reflect strong credit quality as well as record first quarter revenues, with strength in our investment banking business and ongoing momentum from our consumer growth engines. We have continued to make investments in our business to position the company for success. In March, we successfully launched Laurel Road for Doctors, a digital platform tailored to the unique financial needs of healthcare professionals. Additionally, this platform expands our digital reach nationally, for this targeted client segment. Laurel Road for Doctors underscores our commitment to both targeted scale and digital transformation. Credit quality continued to be a strength this quarter. Our strong risk management practices contributed to broad-based improvement in our credit metrics," Chris Gorman, chairman and CEO said.

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
04/19/21
04/19
20:25
04/19/21
20:25
JNJ

Johnson & Johnson

$162.98 /

+0.83 (+0.51%)

, PG

Procter & Gamble

$136.45 /

-0.72 (-0.52%)

, ABT

Abbott

$124.67 /

+0.3 (+0.24%)

, PM

Philip Morris

$91.63 /

-1.29 (-1.39%)

, LMT

Lockheed Martin

$391.87 /

+0.03 (+0.01%)

, TRV

Travelers

$154.45 /

-1.5 (-0.96%)

, FITB

Fifth Third

$37.91 /

-0.29 (-0.76%)

, KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

, OMC

Omnicom

$79.44 /

-0.22 (-0.28%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $2.34... Procter & Gamble (PG), consensus $1.19... Abbott (ABT), consensus $1.27... Philip Morris (PM), consensus $1.40... Lockheed Martin (LMT), consensus $6.30... Travelers (TRV), consensus $2.37... Fifth Third Bancorp (FITB), consensus 69c... KeyCorp (KEY), consensus 48c... Omnicom (OMC), consensus $1.13.

ShowHide Related Items >><<
TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
ABT Abbott
$124.67 /

+0.3 (+0.24%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
PM Philip Morris
$91.63 /

-1.29 (-1.39%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
TRV Travelers
$154.45 /

-1.5 (-0.96%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

04/09/21 Jefferies
Fifth Third price target raised to $44 from $36 at Jefferies
04/07/21 Barclays
Fifth Third price target raised to $43 from $37 at Barclays
04/01/21 Wells Fargo
Fifth Third price target raised to $36 from $28 at Wells Fargo
04/01/21 Deutsche Bank
Fifth Third price target raised to $38 from $30 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
OMC Omnicom
$79.44 /

-0.22 (-0.28%)

12/15/20 Citi
Omnicom price target raised to $75 from $60 at Citi
11/02/20 Evercore ISI
Omnicom upgraded to In Line from Underperform at Evercore ISI
10/30/20 Huber Research
Omnicom upgraded to Overweight from Underweight at Huber Research
10/28/20
Fly Intel: Top five analyst upgrades
TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

Earnings
Notable companies reporting before tomorrow's open » 14:11
04/19/21
04/19
14:11
04/19/21
14:11
JNJ

Johnson & Johnson

$162.24 /

+0.09 (+0.06%)

, PG

Procter & Gamble

$136.73 /

-0.44 (-0.32%)

, ABT

Abbott

$125.24 /

+0.87 (+0.70%)

, PM

Philip Morris

$92.94 /

+0.02 (+0.02%)

, LMT

Lockheed Martin

$390.82 /

-1.02 (-0.26%)

, TRV

Travelers

$154.02 /

-1.93 (-1.24%)

, FITB

Fifth Third

$37.87 /

-0.33 (-0.86%)

, KEY

KeyCorp

$20.54 /

-0.13 (-0.63%)

, OMC

Omnicom

$79.43 /

-0.23 (-0.29%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $2.34... Procter & Gamble (PG), consensus $1.19... Abbott (ABT), consensus $1.27... Philip Morris (PM), consensus $1.40... Lockheed Martin (LMT), consensus $6.30... Travelers (TRV), consensus $2.37... Fifth Third Bancorp (FITB), consensus 69c... KeyCorp (KEY), consensus 48c... Omnicom (OMC), consensus $1.13.

ShowHide Related Items >><<
TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
ABT Abbott
$125.24 /

+0.87 (+0.70%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
PM Philip Morris
$92.94 /

+0.02 (+0.02%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
TRV Travelers
$154.02 /

-1.93 (-1.24%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

04/09/21 Jefferies
Fifth Third price target raised to $44 from $36 at Jefferies
04/07/21 Barclays
Fifth Third price target raised to $43 from $37 at Barclays
04/01/21 Wells Fargo
Fifth Third price target raised to $36 from $28 at Wells Fargo
04/01/21 Deutsche Bank
Fifth Third price target raised to $38 from $30 at Deutsche Bank
KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
OMC Omnicom
$79.43 /

-0.23 (-0.29%)

12/15/20 Citi
Omnicom price target raised to $75 from $60 at Citi
11/02/20 Evercore ISI
Omnicom upgraded to In Line from Underperform at Evercore ISI
10/30/20 Huber Research
Omnicom upgraded to Overweight from Underweight at Huber Research
10/28/20
Fly Intel: Top five analyst upgrades
TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

Recommendations
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett » 09:50
04/19/21
04/19
09:50
04/19/21
09:50
KEY

KeyCorp

$20.68 /

+0.01 (+0.05%)

, CMA

Comerica

$70.16 /

+0.03 (+0.04%)

Don Bilson, who heads…

Don Bilson, who heads event-driven research at Gordon Haskett, said in a note to investors that it is "getting harder to ignore the consolidation wave that is now rolling through the regional banking space." In that context, he noted that "a couple of other banks we have our eye on will be reporting tomorrow," specifically KeyBank (KEY) and Comerica (CMA). While stating that he has "always thought" Comerica "would be a nice pickup" for KeyBank to turn the latter into a national bank, Bilson added that "to be clear, we don't assign a very high probability to this happening." However, "just to hedge our bets," Bilson noted that jet tracking data shows that a KeyBank jet flew to Dallas last Wednesday, adding that data going back 18 months "has never seen KEY in Dallas before." Comerica's corporate headquarters is located in Dallas, Texas.

ShowHide Related Items >><<
KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
03/30/21 Stephens
KeyCorp price target raised to $23 from $20 at Stephens
CMA Comerica
$70.16 /

+0.03 (+0.04%)

04/09/21 Jefferies
Comerica price target raised to $74 from $63 at Jefferies
04/07/21 Barclays
Comerica price target raised to $67 from $65 at Barclays
04/01/21 Wells Fargo
Comerica price target raised to $65 from $54 at Wells Fargo
03/30/21 Stephens
Comerica price target raised to $82 from $74 at Stephens
KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.